Identification of ABC Transporter Interaction of a Novel Cyanoquinoline Radiotracer and Implications for Tumour Imaging by Positron Emission Tomography

about

Identification of ABC Transporter Interaction of a Novel Cyanoquinoline Radiotracer and Implications for Tumour Imaging by Positron Emission Tomography

Item

http://www.wikidata.org/entity/Q28553692

description

2016 nî lūn-bûn

@nan

2016 թուականին հրատարակուած գիտական յօդուած

@hyw

2016 թվականին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Identification of ABC Transpor ...... y Positron Emission Tomography

@ast

Identification of ABC Transpor ...... y Positron Emission Tomography

@en

Identification of ABC Transpor ...... y Positron Emission Tomography

@nl

type

Item

label

Identification of ABC Transpor ...... y Positron Emission Tomography

@ast

Identification of ABC Transpor ...... y Positron Emission Tomography

@en

Identification of ABC Transpor ...... y Positron Emission Tomography

@nl

prefLabel

Identification of ABC Transpor ...... y Positron Emission Tomography

@ast

Identification of ABC Transpor ...... y Positron Emission Tomography

@en

Identification of ABC Transpor ...... y Positron Emission Tomography

@nl

P1476

Identification of ABC Transpor ...... y Positron Emission Tomography

@en

P2093

Alice Beckley

http://www.w3.org/2001/XMLSchema#string

Laurence Carroll

http://www.w3.org/2001/XMLSchema#string

Maciej A Kaliszczak

http://www.w3.org/2001/XMLSchema#string

Quang-De Nguyen

http://www.w3.org/2001/XMLSchema#string

Rozanna L Slade

http://www.w3.org/2001/XMLSchema#string

P2860

The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

Molecular testing guideline for selection of lung cancer patients for EGFR and ALK tyrosine kinase inhibitors: guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular

Open-label phase III trial of panitumumab plus best supportive care compared with best supportive care alone in patients with chemotherapy-refractory metastatic colorectal cancer.

Analysis of tumor specimens at the time of acquired resistance to EGFR-TKI therapy in 155 patients with EGFR-mutant lung cancers.

Acquired EGFR C797S mutation mediates resistance to AZD9291 in non-small cell lung cancer harboring EGFR T790M.

Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma

Untangling the ErbB signalling network

PTEN loss contributes to erlotinib resistance in EGFR-mutant lung cancer by activation of Akt and EGFR

Epidermal growth factor-related peptides and their receptors in human malignancies

New colorimetric cytotoxicity assay for anticancer-drug screening

P304

e0161427

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

3939867

http://www.w3.org/2001/XMLSchema#string

P356

10.1371/JOURNAL.PONE.0161427

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Graham Smith

Federica Pisaneschi

Eric O Aboagye

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27552105

http://www.w3.org/2001/XMLSchema#string

P932

4995014

http://www.w3.org/2001/XMLSchema#string